Al-Razi Pharma Industries
↗Dammam, Saudi Arabia
Al-Razi Pharma Industries is a Saudi national pharmaceutical manufacturer established in 2011, based in Dammam. The company specializes in the production and distribution of various pharmaceutical products, including IV solutions, hemodialysis solutions, oral solid dosage forms (tablets and capsules), eye drops, and innovative oral dissolving films (ODF).
As a subsidiary of the Saeed Raddad Group (SRG), founded in 1982, Al-Razi Pharma leverages extensive regional expertise to serve the Saudi and GCC markets. The company operates in compliance with Saudi Food and Drug Authority (SFDA) cGMP standards and holds ISO 9001:2015 and ISO 13485:2016 certifications, focusing on contributing to healthcare self-sufficiency in the Kingdom in alignment with Saudi Vision 2030.
CLASSIFICATION
Company Type:Biotech
Therapeutic Areas:-
Industry:Pharmaceuticals
Sub-Industry:Generic Pharmaceuticals/Manufacturing
SIZE & FINANCIALS
Employees:51-200
Revenue:$5M-$10M
Founded:2011
Ownership:private
Status:operating
PIPELINE
Stage:Commercial
Lead Drug Stage:Commercial
Modalities:Small molecule, Sterile liquids
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Parent Company:Saeed Raddad Group (SRG)
Key Partnerships:Saeed Raddad Group (Parent company)
COMPETITION
Position:Niche Player
Competitors:Sun Pharma, Torrent Pharmaceuticals, Divis Laboratories, KRKA
LINKS
Website:alrazi-pharma.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Al-Razi Pharma Industries and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Al-Razi Pharma Industries. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.